CFO Hartley Lindsey Marie Buys Big at Axogen, Betting on Nerve‑Repair Tech Amid Volatile Stock
Axogen CFO’s net purchase of 10,796 shares signals confidence amid a volatile market, highlighting potential upside from its nerve‑graft tech pipeline.
3 minutes to read